Steroid-Resistant immune thrombocytopenia: Challenges and solutions
Immune Thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a platelet count of <100 × 109/L in the absence of other underlying causes of thrombocytopenia and increased risk of bleeding. Glucocorticoids are the mainstay drugs of treatment for ITP. The response rate to steroid...
Main Authors: | Abhishekh Basavarajegowda, Vinod K Vishwanath, Ramamoorthy G Jaikumar, Murali Subbaiah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Applied Sciences and Clinical Practice |
Subjects: | |
Online Access: | http://www.jascp.org/article.asp?issn=2772-364X;year=2021;volume=2;issue=2;spage=33;epage=41;aulast=Basavarajegowda |
Similar Items
-
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01) -
Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01) -
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
by: María Eva Mingot-Castellano, et al.
Published: (2023-10-01) -
Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy
by: Ayse Oktem, et al.
Published: (2017-01-01) -
Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022-01-01)